drugset / Trial / NCT00516958

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

NCT00516958

Phase 2 Completed 65 enrolled Oculus Innovative Sciences, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the rates of clinical success of Topical Dermacyn™ vs. Oral Levofloxacin vs. Combined therapy, in subjects with mild diabetic foot infections in non-ischemic ulcers.

Timeline

Start
2007-05
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dermacyn Unknown Topical
Comparator Levofloxacin Small molecule 750 mg Oral
Subject Topical Dermacyn Unknown Topical

Indications